Correction to: Exposure and Health https://doi.org/10.1007/s12403-019-00313-z
A missing/incomplete table caption for Table 4 was discovered after article was published.
Table 4 Risk assessment for the sampling sites. Risk group A: no increased risk (including old people and people with PPI intake); Risk group B: people with increased risk (skin diseases, open wounds, antibiotic therapy and/or devices); Risk group C: people under high risk (immunosuppression or immunodeficiency). Water type 1: “unburdened bathing water” (0/4 positive samples); type 2: “possibly burdened bathing water with hints of burden” (1–2/4 positive samples); type 3: “burdened bathing water” (3–4/4 positive samples). Light grey cells: no health impact expected; Medium grey cells: health impact cannot be excluded, bathing as case-by-case decision after medical consultation; Dark grey cells: bathing not recommended due to possible health impact. +: positive findings. 1: Antibiotic residue, 2: ARB, 3: resistance genes
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Döhla, M., Sib, E., Dericks, B. et al. Correction to: Assessment of the Prevalence of Antibiotic-Resistant Bacteria and the Concentration of Antibiotics in EU Bathing Waters in Western Germany. Expo Health 12, 335 (2020). https://doi.org/10.1007/s12403-019-00315-x